Copyright © 2009 Naoya Mikita et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. E. M. Tan, A. S. Cohen, J. F. Fries, et al., “The 1982 revised criteria for the classification of systemic lupus erythematosus,” Arthritis & Rheumatism, vol. 25, no. 11, pp. 1271–1277, 1982.
2. M. C. Hochberg, “Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus,” Arthritis & Rheumatism, vol. 40, no. 9, p. 1725, 1997.
3. F. Furukawa, “Photosensitivity in cutaneous lupus erythematosus: lessons from mice and men,” Journal of Dermatological Science, vol. 33, no. 2, pp. 81–89, 2003. View at Publisher · View at Google Scholar
4. F. Furukawa, T. Yoshimasu, and A. Hiroi, “SLE and photosensitivity,” Allergy Immunity, vol. 8, pp. 83–89, 2001 (Japanese).
5. R. Watanabe-Fukunaga, C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata, “Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis,” Nature, vol. 356, no. 6367, pp. 314–317, 1992. View at Publisher · View at Google Scholar · View at PubMed
6. F. Furukawa, H. Tanaka, K. Sekita, T. Nakamura, Y. Horiguchi, and Y. Hamashima, “Dermatopathological studies on skin lesions of MRL mice,” Archives of Dermatological Research, vol. 276, no. 3, pp. 186–194, 1984. View at Publisher · View at Google Scholar
7. H. Kanauchi, F. Furukawa, and S. Imamura, “Characterization of cutaneous infiltrates in MRL/lpr mice monitored from onset to the full development of lupus erythematosus-like skin lesions,” Journal of Investigative Dermatology, vol. 96, no. 4, pp. 478–483, 1991. View at Publisher · View at Google Scholar
8. F. Furukawa, H. Kanauchi, H. Wakita, et al., “Spontaneous autoimmune skin lesions of MRL/n mice: autoimmune disease-prone genetic background in relation to Fas-defect MRL/lpr mice,” Journal of Investigative Dermatology, vol. 107, no. 1, pp. 95–100, 1996. View at Publisher · View at Google Scholar
9. F. Furukawa, M. B. Lyon, and D. A. Norris, “Susceptible cytotoxicity to ultraviolet B light in fibroblasts and keratinocytes cultured from autoimmune-prone MRL/Mp-lpr/lpr mice,” Clinical Immunology and Immunopathology, vol. 52, no. 3, pp. 460–472, 1989. View at Publisher · View at Google Scholar
10. Y. Horiguchi, F. Furukawa, G. Ohshio, T. Horio, and S. Imamura, “Effects of ultraviolet light irradiation on the skin of MRL/l mice,” Archives of Dermatological Research, vol. 279, no. 7, pp. 478–483, 1987. View at Publisher · View at Google Scholar
11. P. Lehmann, E. Hölzle, P. Kind, G. Goerz, and G. Plewig, “Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation,” Journal of the American Academy of Dermatology, vol. 22, no. 2, part 1, pp. 181–187, 1990. View at Publisher · View at Google Scholar
12. H. McGrath, Jr., “Ultraviolet-A1 irradiation decreases clinical disease activity and autoantibodies in patients with systemic lupus erythematosus,” Clinical and Experimental Rheumatology, vol. 12, no. 2, pp. 129–135, 1994.
13. H. McGrath, Jr., P. Martínez-Osuna, and F. A. Lee, “Ultraviolet-A1 (340–400 nm) irradiation therapy in systemic lupus erythematosus,” Lupus, vol. 5, no. 4, pp. 269–274, 1996. View at Publisher · View at Google Scholar
14. M. C. A. Polderman, S. le Cessie, T. W. J. Huizinga, and S. Pavel, “Efficacy of UVA-1 cold light as an adjuvant therapy for systemic lupus erythematosus,” Rheumatology, vol. 43, no. 11, pp. 1402–1404, 2004. View at Publisher · View at Google Scholar · View at PubMed
15. S. Pavel, “Light therapy (with UVA-1) for SLE patients: is it a good or bad idea?,” Rheumatology, vol. 45, no. 6, pp. 653–655, 2006. View at Publisher · View at Google Scholar · View at PubMed
16. A. Morita and A. Maeda, “Ultraviolet and immunological function,” Japanese Journal of Dermatology, vol. 118, pp. 1683–1689, 2008 (Japanese).
17. K. Uede, Y. Yamamoto, T. Ikeda, et al., “Ultraviolet A1 and skin,” Aesthetic Dermatology, vol. 13, pp. 154–160, 2003.
18. H. McGrath, Jr., E. Bak, and J. P. Michalski, “Ultraviolet-A light prolongs survival and improves immune function in (New Zealand black $\times$ New Zealand white)${\text{F}}_1$ hybrid mice,” Arthritis & Rheumatism, vol. 30, no. 5, pp. 557–561, 1987. View at Publisher · View at Google Scholar
19. T. Yoshimasu, N. Kanazawa, N. Mikita, and F. Furukawa, “The expression of histamine receptors in skin lesions of MRL/Mp-lpr/lpr mice,” The Open Dermatology Journal, vol. 2, pp. 83–86, 2008. View at Publisher · View at Google Scholar
20. T. Nishide, T. Yoshimasu, T. Ikeda, N. Seo, T. Ohtani, and F. Furukawa, “Cytokine profiles of skin lesions in murine lupus models,” Journal of Dermatological Science Supplement, vol. 1, no. 2, pp. S37–S43, 2005. View at Publisher · View at Google Scholar
21. T. Yoshimasu, T. Nishide, N. Seo, et al., “Susceptibility of T cell receptor-$\alpha$ chain knock-out mice to ultraviolet B light and fluorouracil: a novel model for drug-induced cutaneous lupus erythematosus,” Clinical and Experimental Immunology, vol. 136, no. 2, pp. 245–254, 2004. View at Publisher · View at Google Scholar · View at PubMed
22. T. Ito, N. Seo, H. Yagi, et al., “Unique therapeutic effects of the Japanese-Chinese herbal medicine, Sairei-to, on Th1/Th2 cytokines balance of the autoimmunity of MRL/lpr mice,” Journal of Dermatological Science, vol. 28, no. 3, pp. 198–210, 2002. View at Publisher · View at Google Scholar
23. S. J. Galli, M. Grimbaldeston, and M. Tsai, “Immunomodulatory mast cells: negative, as well as positive, regulators of immunity,” Nature Reviews Immunology, vol. 8, no. 6, pp. 478–486, 2008. View at Publisher · View at Google Scholar · View at PubMed
24. M. A. Grimbaldeston, S. Nakae, J. Kalesnikoff, M. Tsai, and S. J. Galli, “Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B,” Nature Immunology, vol. 8, no. 10, pp. 1095–1104, 2007. View at Publisher · View at Google Scholar · View at PubMed
25. T. Tachibana, F. Furukawa, S. Taniguchi, Y. Hamashima, and S. Imamura, “Histamine metabolism in skin of MRL/I mice,” Archives of Dermatological Research, vol. 278, no. 1, pp. 57–60, 1985. View at Publisher · View at Google Scholar
26. R. L. Thurmond, E. W. Gelfand, and P. J. Dunford, “The role of histamine ${\text{H}}_1$ and ${\text{H}}_4$ receptors in allergic inflammation: the search for new antihistamines,” Nature Reviews Drug Discovery, vol. 7, no. 1, pp. 41–53, 2008. View at Publisher · View at Google Scholar · View at PubMed
27. C. A. Akdis and F. E. R. Simons, “Histamine receptors are hot in immunopharmacology,” European Journal of Pharmacology, vol. 533, no. 1–3, pp. 69–76, 2006. View at Publisher · View at Google Scholar · View at PubMed
28. D. E. Godar, “Light and death: photons and apoptosis,” Journal of Investigative Dermatology Symposium Proceedings, vol. 4, no. 1, pp. 17–23, 1999. View at Publisher · View at Google Scholar
29. S. Guhl, K. Hartmann, S. Tapkenhinrichs, et al., “Ultraviolet irradiation induces apoptosis in human immature, but not in skin mast cells,” Journal of Investigative Dermatology, vol. 121, no. 4, pp. 837–844, 2003. View at Publisher · View at Google Scholar · View at PubMed
30. A. U. Eriksson and R. R. Singh, “Cutting edge: migration of langerhans dendritic cells is impaired in autoimmune dermatitis,” The Journal of Immunology, vol. 181, no. 11, pp. 7468–7472, 2008.
31. V. Parietti, F. Monneaux, M. Décossas, and S. Muller, “Function of $\text{CD}{4}^{+}$,$\text{CD}{25}^{+}$ Treg cells in MRL/lpr mice is compromised by intrinsic defects in antigen-presenting cells and effector T cells,” Arthritis & Rheumatism, vol. 58, no. 6, pp. 1751–1761, 2008. View at Publisher · View at Google Scholar · View at PubMed
32. C.-H. Yang, L. Tian, G.-S. Ling, et al., “Immunological mechanisms and clinical implications of regulatory T cell deficiency in a systemic autoimmune disorder: roles of IL-2 versus IL-15,” European Journal of Immunology, vol. 38, no. 6, pp. 1664–1676, 2008. View at Publisher · View at Google Scholar · View at PubMed
33. F. Furukawa, T. Yoshimasu, Y. Yamamoto, N. Kanazawa, and T. Tachibana, “Mast cells and histamine metabolism in skin lesions from MRL/MP-lpr/lpr mice,” Autoimmunity Reviews, vol. 20, 2009. In press. View at Publisher · View at Google Scholar · View at PubMed
34. H. Endo, “The number of dermal mast cells in acute and chronic dermatosis,” Medical Journal of Kinki University, vol. 28, pp. 239–246, 2003 (Japanese).
35. K. K. Eklund, “Mast cells in the pathogenesis of rheumatic diseases and as potential targets for anti-rheumatic therapy,” Immunological Reviews, vol. 217, no. 1, pp. 38–52, 2007. View at Publisher · View at Google Scholar · View at PubMed